Abstract:AIM To evaluate bioequivalence of lansoprazole and its metabolites 5-hydroxy lansoprazole and lansoprazole sulphone in 22 healthy male vounteers after a single oral dose of 30 mg.METHODS LC:using Diamonsil C_(18) column(250 mm×2.1 mm,5 μm)with preliminary column Octadecy1 C_(18)(4.0 mm×3.05 mm);the mobile phase consiting of acetonitrile-2 mmol·L~(-1) ammonium acetate solution(60∶40,V/V);the flow rate was 0.2 mL·min~(-1);and the column temperature was 40℃.MS:using electrospray ionization (ESI),and selected ion mass spectral (m/z) 368.1/164.1 (lansoprazole),384.0/180.0 (5-hydroxylansoprazole),384/115.9 (lansoprazole sulphone),364.1/188.1(internal standard)to quantify.The plasma samples were treated with acetonitrile precipitation.RESULTS The pharmacokinetic parameters of lansoprazole (test) were:AUC:(12 989.16±13 356.96)μg·h·L~(-1),c_(max)(2 780±1 282)μg·L~(-1),t_(max):(1.73±0.74)h,T_(1/2):(2.74±2.01)h;5-hydroxy lansoprazole(test) were:AUC:(197.51±68.54)μg·h·L~(-1),c_(max):(73.45±39.09)μg·L~(-1),t_(max):(1.59±(0.76))h,T_(1/2):(3.26±1.97)h;lansoprazole sulphone (test) were:AUC:((1 496.74)±2 517.81)μg·h·L~(-1),c_(max):(160.75±146.12)μg·L~(-1),t_(max):(2.18±1.55)h,T_(1/2):(2.94±3.48)h.The pharmacokinetic parameters of lansoprazole (reference) were:AUC:(13 426.99±3 671.51)μg·h·L~(-1),c_(max):(2 945±(1 383))μg·L~(-1),t_(max):(1.90±0.63)h,T_(1/2):(2.53±2.06)h;5-hydroxy lansoprazole (reference) were:AUC:(211.77±(78.40))μg·h·L~(-1),c_(max):(77.70±43.78)μg·L~(-1),t_(max):(1.83±0.65),T_(1/2):(3.03±1.77)h;lansoprazole sulphone (reference) were:AUC:(1 510.80±2 525.48)μg·h·L~(-1),c_(max):(169.20±151.28)μg·L~(-1),t_(max):(2.27±1.37)h,T_(1/2):(2.64±2.96)h.There were no significant differences in all pharmacokinetic parameters between 2 capsules.(P>0.05).CONCLUSION The results of two one-side test show that 2 preparations are bioequivalent.

Relative Bioavailability of Sodium Pantoprazole Enteric-Coated Micro-Pill Capsules in Human Subjects

Study on Bioavailability of Pantoprazole Sodium Enteric - Coated Capsules in Healthy Volunteers

Bioequivalence of Pantoprazole Sodium Enteric-Coated Capsules in Human

Study on bioequivalence of cilostazol table in healthy volunteers

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Bioequivalence of Lansoprazole Enteric Caspsules in Healthy Volunteers

Study on Pharmacokinetics and Bioequivalence of Omeprazole Enteric - coated Capsules in Healthy Volunteers

Pharmacokinetics and Relative Bioavailability of Omeprazole Capsule in HealthyVolunteers after a Single Oral Administration

LC Determination and Bioequivalence Study of Pantoprazole in Human Plasma

Quantification of Pantoprazole in Human Plasma Using LC-MS/MS for Pharmacokinetics and Bioequivalence Study

Relative bioavailability of sodium valproate tablets in healthy volunteers

Bioequivalence of lansoprazole and its metabolites

Pharmacokinetics of pantoprazole sodium in rats

Study on bioequivalence of pravastatin sodium tablets in healthy volunteers

Relative Bioavailability of (s) - ( + ) -Ibuprofen Suspension in Human Subjects

Study on Pharmacokinetics and Bioavailability of Ranitidine Hydrochloride Capsule in Human Body

Relative bioavailability of dirithromycin enteric-coated micro-pill capsule in healthy volunteers

Study on Relative Bioavailability of Two Flunarizine Hydrochloride Capsules

Relative Bioequivalence of Loxoprofen Sodium in Healthy Volunteers

Pharmacokinetics and bioequivalence of roxithromycin capsules in healthy volunteers